About MHAT Heart and Brain EAD
Clinical Trials at MHAT Heart and Brain EAD
During the past decade, MHAT Heart and Brain EAD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Heart and Brain EAD"
#1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MHAT Heart and Brain EAD
According to Clinical.Site data, the most researched conditions in "MHAT Heart and Brain EAD" are
"COVID-19" (4 trials), "Advanced Cancer" (1 trials), "Advanced Cutaneous Squamous Cell Carcinoma" (1 trials), "Child, Hospitalized" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "MHAT Heart and Brain EAD" in a lesser frequency.
Clinical Trials Intervention Types at MHAT Heart and Brain EAD
Most popular intervention types in "MHAT Heart and Brain EAD" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ritonavir" (5 trials), "PF-07321332" (3 trials), "Nirmatrelvir" (2 trials), "Placebo" (2 trials) and "Placebo for nirmatrelvir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT Heart and Brain EAD
The vast majority of trials in "MHAT Heart and Brain EAD" are
7 trials for "All" genders.
Clinical Trials Status at MHAT Heart and Brain EAD
Currently, there are NaN active trials in "MHAT Heart and Brain EAD".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MHAT Heart and Brain EAD,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT Heart and Brain EAD, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".